Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs

被引:40
作者
Romero, Manel
Renard, Pierre
Caignard, Daniel-Henry
Atassi, Ghanen
Solans, Xavier
Constans, Pere
Bailly, Christian
Pujol, Maria Dolors
机构
[1] Univ Barcelona, Fac Farm, CSIC, Unitat Asociada,Lab Quim Farmaceut, E-08028 Barcelona, Spain
[2] Labs Servier, F-92415 Courbevoie, France
[3] Univ Barcelona, Fac Geol, Dept Cristallog Mineral & Diposits Minerals, Barcelona 08028, Spain
[4] INSERM, IRCL, U524, F-59045 Lille, France
关键词
D O I
10.1021/jm061184g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A set of disubstituted tetracyclic lactones has been synthesized and tested for potential antitumor activity. Several of them possess a noticeable cytotoxicity against L1210 and HT-29 colon cells in vitro. Relationships between chain nature and biological properties were sought. Lactones with a pentyl or hexyl substituent at C-11 are the most active ones. The introduction of a functional group at the side chain of C-11 modified the potency; carboxylic acid and primary amine decreased the cytotoxicity, whereas a cyano group increased the activity. An extensive structure-activity relationship study of these derivatives, including carbon homologues and bioisosteres has been performed. The synthesis and cytotoxicity of these compounds are discussed. Two lactones are recognized as potential lead compounds.
引用
收藏
页码:294 / 307
页数:14
相关论文
共 53 条
[21]  
FOYE WO, 1995, PRINCIPLES MED CHEM, P822
[22]  
Frisch M. J., 2016, J AM CHEM SOC, DOI DOI 10.1021/JA205566W
[23]   SYNTHESIS AND DIELS-ALDER REACTIONS OF 1,3-DIMETHYL-4-(PHENYLSULFONYL)-4H-FURO[3,4-B]INDOLE - A NEW ANNULATION STRATEGY FOR THE CONSTRUCTION OF ELLIPTICINE AND ISOELLIPTICINE [J].
GRIBBLE, GW ;
SAULNIER, MG ;
SIBI, MP ;
OBAZANUTAITIS, JA .
JOURNAL OF ORGANIC CHEMISTRY, 1984, 49 (23) :4518-4523
[24]   VMD: Visual molecular dynamics [J].
Humphrey, W ;
Dalke, A ;
Schulten, K .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1996, 14 (01) :33-38
[25]  
*IBM, 2005, IBM OP VIS DAT EXPL
[26]   DESIGN AND SYNTHESIS OF ELLIPTICINIUM SALTS AND 1,2-DIHYDROELLIPTICINES WITH HIGH SELECTIVITIES AGAINST HUMAN CNS CANCERS IN-VITRO [J].
JURAYJ, J ;
HAUGWITZ, RD ;
VARMA, RK ;
PAULL, KD ;
BARRETT, JF ;
CUSHMAN, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (14) :2190-2197
[27]  
KOHN KW, 1975, CANCER RES, V35, P71
[28]   NEW ANTITUMORAL AGENT - 9-HYDROXYELLIPTICINE - POSSIBILITY OF A RATIONAL DESIGN OF ANTI-CANCEROUS DRUGS IN SERIES OF DNA INTERCALATING DRUGS [J].
LEPECQ, JB ;
NGUYENDANGHUNG ;
GOSSE, C ;
PAOLETTI, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (12) :5078-5082
[29]   DRUG-DNA INTERACTIONS - SPECTROSCOPIC AND FOOTPRINTING STUDIES OF SITE AND SEQUENCE SPECIFICITY OF ELLIPTINIUM [J].
MAUFFRET, O ;
RENE, B ;
CONVERT, O ;
MONNOT, M ;
LESCOT, E ;
FERMANDJIAN, S .
BIOPOLYMERS, 1991, 31 (11) :1325-1341
[30]   2,2-Dimethyl-2H-anthra[2,3-b]pyran-6,11-diones:: A new class of cytotoxic compounds [J].
Melliou, E ;
Magiatis, P ;
Mitaku, S ;
Skaltsounis, AL ;
Pierré, A ;
Atassi, G ;
Renard, P .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (03) :607-612